CytomX Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy CytomX Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for CytomX Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for CytomX Therapeutics Inc. is CTMX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
CytomX Therapeutics Inc. has its primary listing on NASDAQ. You can trade CytomX Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, CytomX Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include CytomX Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like CytomX Therapeutics Inc..